Recently announced data from the PoNSTEP trial showed that treatment with Helius’ Portable Neuromodulation Stimulator (PoNS), a non-implantable, orally applied therapy, resulted in improved gait deficit among patients with multiple sclerosis (MS).
No serious adverse events related to the PoNS device were reported in the MS RCTs or in use in clinical rehabilitation settings to treat balance and gait disorders.
Some individuals have reported headaches, fatigue, and excess salivation. Excess salivation during training sessions often occurs but generally improves as patients get used to wearing the mouthpiece.
Indication
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.
Contraindications
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).
Electrical stimulation should not be used:
The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.
Use with caution
Electrical stimulation should only be used after seeking professional medical advice, and with caution in patients with any of the following:
Patients who are seeking more information on how to get PoNS can email us at [email protected], or fill out our contact form: